tiprankstipranks
BB Biotech AG (DE:BBZA)
XETRA:BBZA
Germany Market
BBZA
BB Biotech
RESEARCH TOOLSreports

BB Biotech (BBZA) Financial Statements

14 Followers

BB Biotech Financial Overview

BB Biotech's market cap is currently €3.09B. The company's EPS TTM is €24.5; its P/E ratio is 2.22; and it has a dividend yield of 4.46%. BB Biotech is scheduled to report earnings on July 24, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueCHF 76.81MCHF 111.63MCHF 35.00KCHF 4.00KCHF -396.22M
Gross ProfitCHF 76.76MCHF 111.63MCHF 35.00KCHF 4.00KCHF -396.22M
Operating IncomeCHF 586.83MCHF 84.40MCHF -29.93MCHF -38.62MCHF -52.59M
EBITDACHF 578.64MCHF 80.33MCHF -34.60MCHF -43.01MCHF -59.20M
Net IncomeCHF 578.13MCHF 75.90MCHF -206.61MCHF -357.81MCHF -404.81M
Balance Sheet
Cash & Short-Term InvestmentsCHF 99.41MCHF 2.41BCHF 2.64BCHF 3.05BCHF 3.64B
Total AssetsCHF 2.79BCHF 2.41BCHF 2.64BCHF 3.05BCHF 3.64B
Total DebtCHF 0.00CHF 117.50MCHF 304.90MCHF 363.00MCHF 355.00M
Net DebtCHF -98.22MCHF 117.04MCHF 304.40MCHF 361.05MCHF 352.17M
Total LiabilitiesCHF 6.97MCHF 121.11MCHF 313.94MCHF 367.25MCHF 355.00M
Stockholders' EquityCHF 2.78BCHF 2.29BCHF 2.32BCHF 2.69BCHF 3.28B
Cash Flow
Free Cash FlowCHF 309.14MCHF 304.56MCHF 218.28MCHF -357.81MCHF -94.79M
Operating Cash FlowCHF 309.14MCHF 304.56MCHF 218.28MCHF -357.81MCHF -94.79M
Investing Cash FlowCHF 0.00CHF 0.00CHF 0.00CHF 588.94MCHF 0.00
Financing Cash FlowCHF -203.19MCHF -305.20MCHF -220.21MCHF -233.27MCHF 91.77M
Currency in CHF

BB Biotech Earnings and Revenue History

Income Statement >

BB Biotech Debt to Assets

Balance Sheet >

BB Biotech Cash Flow

Cash Flow >

BB Biotech Forecast EPS vs Actual EPS

Earnings >